This case series focuses on the impact of sacral neuromodulation on quality of life (QOL). InterStim therapy, a form of sacral neuromodulation, has been found to be effective on urinary leakage and frequency, but its effect on QOL has not been determined.
This study is a prospective chart review of 3 female patients who underwent implantation of the InterStim device. All patients completed the King's Health Questionnaire on the morning of the procedure and at 3 months postimplantation.
Mean age of the 3 subjects was 68 years (range: 63–76 years) and there was variability in patient comorbidities, duration, and range of symptoms. Each patient was evaluated by a family nurse practitioner and was deemed appropriate for implantation after a successful trial period.
Implantation of the InterStim device had a positive impact on QOL for 2 of the patients. The oldest patient, who also had the lowest perceived general health status before implantation and who reported coital incontinence, did not have improvement in QOL.
Age, health status before implantation, and coital incontinence seem to have a negative impact on QOL outcomes in patients who undergo InterStim implantation.
1Department of Physical Therapy, University of Mary, Bismarck, North Dakota.
2Wishek Community Hospital, North Dakota.
3St Alexius Medical Center, Bismarck, North Dakota.
4Champion Rehab/Country Manor, Sartell, Minnesota.
5Bigstone Therapies, Watertown, South Dakota.
The authors declare no conflicts of interest.